Fibrinolytic activity of the urine in patients with arterial hypertension with different efficacy of antihypertensive treatment
- Authors: Podorol'skaya LV1, Chumakova EL1, Lobanova EV1, Alekseeva LA1
-
Affiliations:
- Issue: No 5 (2010)
- Pages: 50-52
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/245955
- ID: 245955
Cite item
Full Text
Abstract
Aim. Assessment of urinary fibrinolytic activity in patients with arterial hypertension.
Methods. Urinary fibrinolytic activity parameters were studied in 43 patients with arterial hypertension in comparison with 37 young and 9 elderly nornotensive subjects.
Results. In patients with arterial hypertension, especially inadequately treated, urinary activity of urokinase is depressed. Uncontrolled arterial hypertension is also associated with elevation of urinary tissue plasminogene activator concentration.
Conclusion. Arterial hypertension, especially uncontrolled, is associated with disturbances in urinary fibrinolytic system activity.
Methods. Urinary fibrinolytic activity parameters were studied in 43 patients with arterial hypertension in comparison with 37 young and 9 elderly nornotensive subjects.
Results. In patients with arterial hypertension, especially inadequately treated, urinary activity of urokinase is depressed. Uncontrolled arterial hypertension is also associated with elevation of urinary tissue plasminogene activator concentration.
Conclusion. Arterial hypertension, especially uncontrolled, is associated with disturbances in urinary fibrinolytic system activity.
References
- .Яровая Г.А., Блохина Т.А., Пешкова Е.А. Контактная фаза. Новые представления о механизмах и биорегулирующих функциях. Биохимия 2002; 67(1): 16-29
- Fodari K., Zoppi A. Is the effect of antihypertensive drugs on platelet aggregalibity and fibrinolysis clinically relevant? Am. J. Cardiovasc. Drugs 2005; 5(4): 211-223
- Fodari K., Zoppi A. Antihypertensive drugs and fibrinolytic function. Am.J.Hypertens.2006;19(12):1293-1299
- Felmeden D.C., Lip G.Y. The renin-angiotensin-aldosterone system and fibrinolysis. J.Renin Angiotensin Aldosterone Syst. 2000;1(3): 240-244
- Speidl W.S., Zeiner A., Nikfardjam M., et al. An increase of C-reactive protein is associated with enhance activation of endogenous fibrinolysis. Am. J. Cell Cardiol. 2005;45(1):30-34
- Epstein M. Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction - a paradigm shift. J. Hypertens.2001; 19(5): 829-842
- Андреенко Г.В. (ред.) Методы определения фибринолитической активности крови. М., МГУ; 1981
- Kabori H., Harrison-Renard L.M., Navar L.R. Urinary excretion of angiotensin reflects intrarenal angiotensin production. Kidney international 2002; 61(2): 579-585
- Yamamoto T., Nakagava T., Suzuki H., et al. Urinary angiotensin as a marker of intrarenal angiotensin II activity, associated with deterioration of renal function in patients with chronic kidney disease. J.Am.Soc.Nephrol. 2007; 18(5): 1558-1565
- Щербак А.В., Балкаров И.М., Козловская Л.В. и др. Фибринолитическая активность мочи как показатель поражения почек при нарушении обмена мочевой кислоты. Тер.архив 2001; 6: 43-46
- Dieles A.W., Smid D.M., Sponk H.M., et al. Changes in fibrinolytic activity after angiotensin 11 receptor blockage in therapy resistant hypertensive patients. J.Thromb. Haemost. 2007; 5(7):1509-1515
- Белова Л.А. Ангиотензин II-генерирующие ферменты. Биохимия 2000; 65(12):1337-1345
- Степанова В.В.,Ткачук В.А. Урокиназа как мультидоменный белок и полифункциональный регулятор клеток. Биохимия 2002; 67(1):127-138
- Кудряшов Б.А. Биологические проблемы регуляции жидкого состояния крови и ее свертывания. М.,Медицина; 1975
- Johnson R.J.,Freig D.I.,Nakagawa T., et al. Pathogenesis of essential hypertension:historical paradigms and modern insigts. J.Hypertens. 2008; 26(3): 381-394
Supplementary files
